Annovis Bio, Inc.ANVSNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank88
3Y CAGR+5.2%
5Y CAGR+34.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+5.2%/yr
vs +144.5%/yr prior
5Y CAGR
+34.9%/yr
Recent deceleration
Acceleration
-139.3pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $29.70M | +11.2% |
| 2024 | $26.69M | -40.7% |
| 2023 | $45.03M | +76.5% |
| 2022 | $25.51M | +75.5% |
| 2021 | $14.54M | +118.9% |
| 2020 | $6.64M | +313.5% |
| 2019 | $1.61M | +124.9% |
| 2018 | $713937.00 | +4.6% |
| 2017 | $682433.00 | - |